Showing results (1631-1640 of 1,768) with videos related to

Sort By:
Pageof 177
JAMA Neurology|November 13, 2013
Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skippingKaren Anthony, Virginia Arechavala-Gomeza, Valeria Ricotti, et al.
JAMA Neurology|December 11, 2013
Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexateJae-Won Hyun, Su-Hyun Kim, Heon Yoo, et al.
JAMA Neurology|December 11, 2013
Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiencyEugene F Diekman, Tom J de Koning, Nanda M Verhoeven-Duif, et al.
JAMA Neurology|December 11, 2013
Prognosis of untreated strokes due to anterior circulation proximal intracranial arterial occlusions detected by use of computed tomography angiographyFabricio O Lima, Karen L Furie, Gisele S Silva, et al.
JAMA Neurology|August 27, 2014
Effect of advancing age on outcomes of deep brain stimulation for Parkinson diseaseMichael R DeLong, Kevin T Huang, John Gallis, et al.
JAMA Neurology|October 28, 2014
Dementia risk after traumatic brain injury vs nonbrain trauma: the role of age and severityRaquel C Gardner, James F Burke, Jasmine Nettiksimmons, et al.
JAMA Neurology|December 25, 2013
Unusual case of bilateral caudate infarcts following pituitary apoplexyTania Rebeiz, Wilson Cueva, Agnieszka Ardelt
JAMA Neurology|April 6, 2026
Teleneurology vs On-Site Neurology Consultation for Postadmission Hospital Care of StrokeJanina R Behrens, Maximilian Kaffes, Annette Aigner, et al.
JAMA Neurology|March 20, 2026
Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical TrialRajesh Pahwa, Elena Moro, Alberto J Espay, et al.
JAMA Neurology|March 20, 2026
Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical TrialHubert H Fernandez, Stuart H Isaacson, Robert A Hauser, et al.
Pageof 177